Results for tag: "Hyaluronic Acid Viscosupplementation"

Hyaluronic acid viscosupplementation is a medical treatment that involves the injection of hyaluronic acid into joints, primarily to alleviate knee pain caused by osteoarthritis. This procedure falls outside of the conventional categorization of vitamins and dietary supplements, although it shares the underlying premise of supplementing a naturally occurring substance in the body to improve health outcomes. In the broader context of health supplements, the market for viscosupplementation is more narrowly focused and clinically oriented. Unlike over-the-counter vitamins and dietary supplements that cater to a general populace aiming to maintain or enhance wellness, hyaluronic acid viscosupplementation is generally administered by healthcare professionals and is often part of a targeted therapeutic regimen for patients with specific joint disorders. Companies operating in the hyaluronic acid viscosupplementation market are part of the pharmaceutical and medical device sectors. Some prominent players include Sanofi (through its subsidiary Genzyme), Anika Therapeutics, Ferring Pharmaceuticals, and Seikagaku Corporation. Orthopedic and pharmaceutical companies such as Zimmer Biomet, Bioventus, and Smith & Nephew also offer viscosupplementation products. These companies compete in the development, manufacturing, and marketing of hyaluronic acid formulations and injection systems designed to relieve pain and improve joint function in patients with osteoarthritis. Show Less Read more